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Abstract
Background: Age-related macular degeneration (AMD) is the leading cause of legal blindness in the elderly population.
Debris (termed drusen) below the retinal pigment epithelium (RPE) have been recognized as a risk factor for dry AMD and
its progression to wet AMD, which is characterized by choroidal neovascularization (CNV). The underlying mechanism of
how drusen might elicit CNV remains undefined. Cigarette smoking, oxidative damage to the RPE and inflammation are
postulated to be involved in the pathophysiology of the disease. To better understand the cellular mechanism(s) linking
oxidative stress and inflammation to AMD, we examined the expression of pro-inflammatory monocyte chemoattractant
protein-1 (MCP-1), pro-angiogenic vascular endothelial growth factor (VEGF) and anti-angiogenic pigment epithelial derived
factor (PEDF) in RPE from smoker patients with AMD. We also evaluated the effects of hydroquinone (HQ), a major pro-
oxidant in cigarette smoke on MCP-1, VEGF and PEDF expression in cultured ARPE-19 cells and RPE/choroids from C57BL/6
mice.
Principal Findings: MCP-1, VEGF and PEDF expression was examined by real-time PCR, Western blot, and ELISA. Low levels
of MCP-1 protein were detected in RPE from AMD smoker patients relative to controls. Both MCP-1 mRNA and protein were
downregulated in ARPE-19 cells and RPE/choroids from C57BL/6 mice after 5 days and 3 weeks of exposure to HQ-induced
oxidative injury. VEGF protein expression was increased and PEDF protein expression was decreased in RPE from smoker
patients with AMD versus controls resulting in increased VEGF/PEDF ratio. Treatment with HQ for 5 days and 3 weeks
increased the VEGF/PEDF ratio in vitro and in vivo.
Conclusion: We propose that impaired RPE-derived MCP-1-mediated scavenging macrophages recruitment and
phagocytosis might lead to incomplete clearance of proinflammatory debris and infiltration of proangiogenic macrophages
which along with increased VEGF/PEDF ratio favoring angiogenesis might promote drusen accumulation and progression to
CNV in smoker patients with dry AMD.
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Introduction
Age-related macular degeneration (AMD) is the main cause of
untreatable blindness among older adults in the developed world
and has a devastating impact on quality of life [1,2,3,4]. Although
much effort is invested in understanding this condition, there is
neither a cure nor a way to prevent it, and treatment options are
very limited. AMD affects more than 1.75 million individuals in
the United States [5] and it is estimated that more than 300,000
new cases are diagnosed annually [1,3]. Unless better preventive
treatments emerge, this number is expected to climb threatening
to reach epidemic proportions given the longer life expectancies
[6]. The development of novel therapeutic approaches to provide
more effective disease control is critical and requires a better
understanding of the different pathophysiological processes
underlying the critical steps in the etiology of AMD.
Histopathological signs of dry AMD, the early stage of the
disease, include the presence of waste material in the form of focal
deposits named drusen below the retinal pigment epithelium
(RPE) and within Bruch’s membrane, a stratified extracellular
matrix situated between the choriocapillaris and RPE [4,7].
Drusen increase in size and number as the disease progresses.
Geographic atrophy represents the advanced stage of dry AMD
and is characterized by progressive destruction of RPE cells and
photoreceptors. Only a fraction of patients with drusen will
develop wet AMD, the most rapidly progressing form which
accounts for 80 to 90% of cases of severe vision loss related to the
disease. The presence, size and area covered by drusen confer a
significant risk for the development and progression to wet AMD
[8,9,10]. Wet AMD is characterized by the growth of leaky new
abnormal blood vessels under the RPE from the subjacent choroid
known as choroidal neovascularization (CNV). Our understanding
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still much debate as to why and how the disease progresses and
what sequence of cellular events lead to the progression of dry to
wet AMD. Overall, the mechanism by which drusen might elicit
CNV remains undefined.
Although the pathophysiology of AMD is not yet fully
understood, this multifactorial degenerative disease likely arises
from a complex interaction of genetic and environmental risk
factors [2,11] among which cigarette smoking is the single most
important for onset and severity of all forms of AMD
[4,12,13,14,15]. Overwhelming evidence shows that smokers have
a greater prevalence of AMD compared with non smokers
[13,14,16,17,18,19,20,21]. Former smokers remain at high risk for
AMD [19] and passive smoking (also called secondhand smoke or
environmental tobacco smoke) almost doubles the risk of AMD
[22]. Cigarette smoking may contribute to the etiology of AMD by
causing oxidative damage to the RPE strategically located between
the neural retina and the vascular choroid [23]. Tar within
cigarette smoke contains a large number of pro-oxidant com-
pounds among which hydroquinone (HQ) is the most abundant.
HQ is an oxidant of special relevance due to its presence not only
in cigarette smoke but also in foodstuff and atmospheric pollutants
as well as its widespread occurrence in nature. We and others have
shown that smoking and HQ cause oxidative damage to the RPE
in vitro and vivo which might play a key role in the pathogenesis of
AMD [23,24,25,26,27,28,29]. However, little is known about how
the RPE may contribute to the progression of dry AMD to the wet
form of the disease and the role played by cigarette smoke-related
HQ-induced oxidative stress.
Aberrant expression of chemokines occurs in a variety of
diseases that have an inflammatory component. A growing
collection of evidence suggests that inflammation is a key cellular
process that plays a central role in the pathogenesis of AMD
[30,31,32,33] and its progression to CNV [34]. Highly specialized
RPE cells play a pivotal role in the maintenance of the outer retina
by secreting several cytokines including monocyte chemoattractant
protein-1 (MCP-1) [35,36], which has been suggested to be
implicated in the pathogenesis of AMD [37,38]. RPE cells can
secrete MCP-1 in the direction of choroidal blood vessels during
inflammatory responses therefore suggesting that RPE cells might
promote macrophage recruitment to the choroid from circulating
monocytes [39]. MCP-1 expression has not been investigated in
RPE from patients with AMD nor has been the regulation of RPE-
derived MCP-1 expression following cigarette smoke-related HQ-
mediated oxidative injury.
Angiogenesis is a highly complex biological process that involves
a delicate balance between numerous stimulators and inhibitors,
each regulated by multiple control systems. CNV-related angio-
genesis requires an alteration in the concentration of molecules
that stimulate or inhibit growth of new blood vessels [40]. Vascular
endothelial growth factor (VEGF), constitutively produced and
secreted by RPE in culture [41] [42,43,44,45,46,47,48,49], is a
major angiogenic cytokine central to the development of wet
AMD [42,43,44,45]. VEGF regulates endothelial cells prolifera-
tion, migration and survival [50]. Interestingly, secretion of VEGF
by RPE cells is polarized towards Bruch’s membrane [51]. There
is ample clinical evidence that VEGF expression is increased in
surgically excised AMD-associated choroidal neovascular mem-
branes [46,47,48]. Eyes with early forms of AMD have increased
expression of VEGF in the RPE and the vitreous of eyes with
CNV have increased concentration of VEGF [46]. Similar
observations have been made in animal models of CNV [43,52].
Furthermore, Reich et al reported that subretinal injection of
VEGF siRNA significantly inhibited the growth of laser-induced
CNV in a mouse model [49]. PEDF, a potent angiogenic inhibitor
[53] secreted by RPE cells [54,55,56], counterbalances the effects
of VEGF and modulates the formation of CNV [54,55]. A
decrease in PEDF expression has been reported in eyes with
AMD, therefore disrupting the critical balance between VEGF
and PEDF that may lead to pathological angiogenesis and be
permissive for the development of CNV [54]. PEDF levels decline
in the vitreous of patients with CNV [56]. However, until now,
there is no report in the literature examining VEGF and PEDF
expression in RPE from AMD patients or evaluating whether or
not cigarette smoke-related HQ-induced oxidative stress has the
potential to dysregulate the VEGF/PEDF balance in RPE cells.
Given their critical role in AMD and that oxidative damage to
the RPE and inflammation appear to be central in the
pathogenesis of the disease, we studied the effect of different HQ
concentrations and durations of exposure on the regulation of
MCP-1, VEGF and PEDF expression in RPE in vitro and in vivo.
We also studied the expression of these chemokines in RPE from
smoker patients diagnosed with AMD. Better understanding of the
cellular events leading to wet AMD is critical to the development
of new therapeutic approaches that may help slow down the
progression of this vision threatening disease in the elderly.
Results
MCP-1 expression is downregulated in RPE from smoker
patients with AMD
Declining production of MCP-1 by RPE and macrophage
recruitment may be implicated in AMD [37]. MCP-1 expression
has not been studied in human RPE from smoker AMD patients.
With the use of Western blot analysis, we investigated the
expression of MCP-1 in RPE lysates from smoker patients
diagnosed with AMD and control non-smoker donors with no
known history of eye diseases. In normal donors, we found that
RPE express high levels of MCP-1 (Figure 1). For the first time, we
showed that MCP-1 expression is robustly downregulated by
,59% in RPE from AMD patients compared with non-smoker
controls (41.260.8 versus 100.0610.2%, p,0.01) (Figure 1).These
findings suggest that MCP-1 might play an important role in the
pathobiology of AMD. Diminished expression of MCP-1 might
have implications in the recruitment of scavenging macrophages
which are responsible for clearing debris from the sub-RPE space.
Sustained and repetitive oxidative injury with HQ
decreases MCP-1 expression in RPE cells
Prolonged oxidative injury has been suggested as one of the
causes of a number of retinal pathologic conditions, including
AMD. We have previously investigated the effects of repetitive
acute (6 hours every 3 days for 4 weeks) and transient (6 hours
followed by a recovery phase, every 5 days for 6 weeks) exposure of
ARPE-19 cells to HQ on matrix metalloproteinase-2 activity and
extracellular matrix turnover relevant to the pathogenesis of dry
AMD [26]. Regulation of RPE-derived MCP-1 expression
following HQ-mediated oxidative injury has not been investigated.
Here, we found that sustained exposure of ARPE-19 cells to HQ
10 mM every 24 hours for 5 consecutive days decreased MCP-1
mRNA expression by 24% compared with control cells
(0.7660.02 versus 1.060.03, p,0.001) (Figure 2A) with a
concomitant moderate ,12% decrease in MCP-1 protein released
in the supernatants as measured by ELISA (88.2761.8 versus
100.062.1%, p,0.01) (Figure 2B) without causing any cell death
(94.666.1% of cells survived after treatment with NT versus
100.063.5% in control conditions, p.0.05). We also tested the
effect of repetitive long-term exposure to sub-lethal oxidative stress
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24 hours for 3 consecutive weeks. We observed a ,20% decline in
MCP-1 mRNA expression (0.8060.9 versus 1.060.01, p,0.05)
(Figure 2C) with a concomitant ,27% decrease in protein
secretion (72.95612.27 versus 100.062.0% p,0.05) (Figure 2D)
relative to control cells without any cell death (95.465.9% of cells
survived after treatment with NT versus 100.061.3% in control
conditions, p.0.05). These observations suggest that cigarette
smoke-related HQ-induced downregulation of RPE-derived
MCP-1 expression may play an important role in the pathogenesis
of AMD.
HQ-induced oxidative injury decreases MCP-1 expression
in RPE/choroids from C57BL/6 mice
Based on the above observations obtained in vitro on ARPE-19
cells, we hypothesized that pro-oxidant HQ might also regulate
MCP-1 expressioninmicetreatedwith0.8%HQindrinkingwater.
A longer exposure for 5 days almost completely abolished MCP-1
mRNA expression compared with control mice (0.0460.006 versus
1.060.12, p,0.001) (Figure 3A) but the expressed protein was only
,46% downregulated (54.166.2 versus 100.060.01%, p,0.01)
(Figure 3B). After 3 consecutive weeks of exposure to HQ, MCP-1
mRNA expression in RPE/choroids was dramatically downregu-
lated compared with a 5 day-treatment but remained 39% lower
compared with control mice (0.6160.13 versus 1.060.12, p,0.05)
(Figure 3A). At 3 weeks, MCP-1 expression was decreased by
,30% at the translational level (70.564.3 versus 100.060.01%,
p,0.01) (Figure 3B). These observations are consistent with
aforementioned data on ARPE-19 cells at 5 days and 3 weeks
indicating that cumulative cigarette-smoke related HQ-induced
oxidative injury might decline RPE-derived MCP-1expression
therefore inhibiting the recruitment of scavenging macrophages
therefore playing a crucial role in the progression of AMD.
VEGF-to-PEDF ratio is increased in RPE from smoker
patients with AMD
Dysregulated expression of VEGF and PEDF by RPE cells may
be involved in the pathogenesis of CNV. Here, we reported
that VEGF is expressed at higher levels (198.0612.5 versus
100.0628.9%, p,0.05) (Fig. 4A and 4B) and PEDF at lower levels
(40.7065.1 versus 100.067.9, p,0.01) (Fig. 4A and 4C) in RPE
from AMD smoker patients compared to RPE from non-smoker
control donors as shown by Western blot. Overall, the VEGF-to-
PEDF ratio was increased by ,4.0-fold (5.1261.3 versus
100.060.2, p,0.05) (Fig. 4D) in RPE from smoker AMD patients
relative to non-smoker control donors. Unbalanced expression of
VEGF and PEDF might promote angiogenesis and therefore lead
to the conversion of dry AMD to CNV.
Sustained and repetitive oxidative injury with HQ
increases the VEGF-to-PEDF ratio in RPE cells
We showed that VEGF mRNA expression was slightly
decreased by ,9% (0.9160.01 versus 1.0060.02, p,0.05)
(Figure 5A) while VEGF protein expression remained unchanged
(91.965.3 versus 100.063.2%, p=0.17) in response to sustained
exposure to HQ 10 mM every 24 hours for 5 consecutive days
(Figure 5B). In addition, PEDF mRNA expression was not affected
(Figure 5C) while the amount of PEDF protein released in the
supernatants was decreased by ,28% relative to control cells
(71.47611.34 versus 100.064.45, p,0.05) (Figure 5D). These
results indicate a moderate ,30% increase in VEGF/PEDF ratio
(1.3060.3 versus 1.0060.01, p,0.05) which may switch the
balance in favor of angiogenesis stimulation over inhibition
(Fig. 5E).
Following repetitive oxidative injury with HQ 50 mM every 4
days for 24 hours for 3 consecutive weeks, VEGF expression was
not changed either at the transcriptional (Figure 6A) or the
translational level (Figure 6B). Contrastingly, PEDF mRNA
expression was robustly decreased by 60% (0.460.04 versus
1.060.08, p,0.0001) (Figure 6C) compared with untreated cells
which translated into ,46% decreased PEDF protein secretion in
the supernatant (55.9562.63 versus 100.069.59% p,0.01)
(Figure 6D). These data demonstrate ,35% increase in VEGF
to PEDF ratio which may switch the balance in favor of
angiogenesis stimulation over inhibition (Fig. 6E).
HQ-induced oxidative injury dysregulates the balance
between VEGF and PEDF expression in RPE/choroids
from C57BL/6 mice
The observations reported above led us to investigate the impact
of HQ-induced oxidative damage on VEGF and PEDF expression
in RPE/choroids from C57BL/6 mice treated with 0.8% HQ in
drinking water for different periods of time. Our data show that
VEGF mRNA levels were ,40% higher than in control mice after
exposure to HQ for 5 days (1.4060.13 versus 1.0260.05%,
p,0.01) (Fig. 7A) whereas the expressed protein was upregulated
by ,109% (208.0612.1 versus 100.060.02%, p,0.01) (Fig. 7C).
However, VEGF mRNA expression was not modified after 3
consecutive weeks of oxidative stress (0.8760.03 versus 1.026
0.05, p.0.05) (Fig. 7A) whereas VEGF protein expression was
increased by ,60% relative to control mice (160.366.4 versus
100.060.02%, p,0.05) (Fig. 7C). In addition, 5 days of exposure
to HQ led to ,80% increase in PEDF mRNA expression relative
to control (1.8060.11 versus 1.0060.07%, p,0.01) (Fig. 7B) while
the protein levels were increased by ,50% (149.761.5 versus
100.060.03%, p,0.05) (Fig. 7C). After 3 weeks of oxidative stress
with HQ, PEDF mRNA expression was not modified in RPE/
Figure 1. MCP-1 expression is decreased in RPE from smoker
AMD patients. MCP-1 protein expression was evaluated by Western
blot in RPE lysates from 3 smoker donors with AMD and 3 age-matched
non smoker controls with no known history of eye disease. GAPDH
served as loading control. Top: representative Western blots of the
indicated proteins. The numbers to the left are molecular weights in
kilodaltons (KDa). Bottom: average densitometry results. Data are
expressed as percentage of control and are means 6 SE. **p,0.01
versus control.
doi:10.1371/journal.pone.0016722.g001
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p.0.05) (Fig. 7B) and PEDF protein expression was increased by
,25% compared to control (124.860.06 versus 100.060.03%,
p,0.05) (Fig. 7C). Overall, exposure to HQ for 5 days and 3
weeks enhanced the VEGF-to-PEDF ratio in mice RPE/choroid
complexes by ,45% (1.4560.04 versus 1.060.01, p,0.05) and
30% (1.3360.06 versus 1.060.01, p,0.05) respectively (Fig. 7D).
Our data demonstrate changes in the levels of VEGF and PEDF in
RPE/choroids from mice following HQ-induced oxidative injury
revealing a disturbance of the angiogenic homeostatic balance
which may play a role in the development of CNV.
Discussion
Results of these experiments indicate that expression of MCP-1,
VEGF and PEDF, key mediators pertinent to inflammation and
angiogenesis are dysregulated in RPE from smoker patients with
AMD as well as in cultured human RPE cells and RPE/choroids
from C57BL/6 mice in response to various levels of pro-oxidant
HQ and durations of exposure. These observations may have
strong implications for the formation and accumulation of drusen
and progression to CNV in smoker patients with dry AMD.
Although a cause and effect relationship has not been
established, the presence, size and area covered by drusen within
Bruch’s membrane constitute a strong epidemiological risk
indicator for the development and progression of the blinding
end-stage form of AMD [8,9,10]. The mechanism of how drusen
might elicit CNV remains undefined. However, evidence impli-
cates cigarette smoking, oxidative stress and inflammation as
important components in the pathogenesis and progression of the
disease [23,24,25,26,27,32]. While it is largely recognized that
macrophages accumulate in AMD lesions [57,58,59,60,61,62,63],
there is ambiguity surrounding their role in the disease process
with conflicting evidence regarding whether they might be helpful
by scavenging accumulated debris and therefore protecting against
CNV or harmful by stimulating CNV [64]. This might be due to
the largely observational nature of human samples but also
probably reflects different functions macrophages serve during
distinct phases of the disease. Previous observations made using
mouse animal models suggest that MCP-1 and chemokine
receptor–2 might be involved in the etiology of AMD and that
macrophage dysfunction may have a central role in the early stage
of AMD development [37,38]. Indeed, it has been proposed that
the spontaneous disappearance of drusen in patients with AMD
Figure 2. Sustained and repetitive HQ-induced oxidative injury decreases on MCP-1 expression in human RPE cells. Confluent serum-
starved ARPE-19 cells were treated with (A, B)1 0mM HQ every 24 hours for 5 consecutive days or (C, D)5 0mM HQ every 4 days for 24 hours for 3
consecutive weeks in phenol red-free 0.1% FBS medium. Total RNA was extracted to assess MCP-1 mRNA expression by real-time PCR (A, C). GAPDH
was used as internal control. Supernatants were collected to assess MCP-1 protein concentration by ELISA (B, D). Data are mean6 SE and represent
the average results of 3 independent experiments run in duplicate. * is p,0.05, ** is p,0.01 and *** is p,0.001 versus control.
doi:10.1371/journal.pone.0016722.g002
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beneficial role of macrophages [31]. Although it has been recently
demonstrated that previously described features of MCP-1
knockout ice that are similar to AMD [37] may only be age-
related changes [65], the lack of direct studies on MCP-1 in
Figure 3. MCP-1 expression is decreased in RPE/choroids from
mice exposed to HQ. (A) MCP-1 mRNA expression was downregu-
lated in response to HQ-induced oxidative injury. Total RNA was
extracted from microdissected RPE/choroid complexes after 5 days and
3 weeks of exposure to HQ in drinking water (0.8%). MCP-1 mRNA
expression was measured by real-time PCR. GAPDH was used as internal
control (n=5 eyes per group). (B) MCP-1 protein expression was
downregulated in response to HQ-induced oxidative injury. Total
protein was extracted from microdissected RPE/choroid complexes
after 5 days and 3 weeks of exposure to HQ in drinking water (0.8%).
Equivalent amounts of protein from 5 eyes per group were pooled for
each lane. MCP-1 protein expression was evaluated by Western blot and
normalized to GAPDH. Top: representative Western blot gel. The
numbers to the left are molecular weights in kilodaltons (KDa). Bottom:
average densitometry results. Data are expressed as percentage of
control and are means 6 SE. * is p,0.05 and **p,0.01 versus control.
doi:10.1371/journal.pone.0016722.g003
Figure 4. VEGF expression is increased and PEDF expression
decreased in RPE from AMD patients. VEGF and PEDF protein
expression was evaluated by Western blot in RPE lysates from 3 smoker
donors with AMD and 3 non smoker controls with no known history of
eye disease. GAPDH served as loading control. (A) Representative
Western blots of the indicated proteins. The numbers to the left are
molecular weights in kilodaltons (KDa). (B, C) Average densitometry
results. (D) VEGF-to-PEDF protein ratio. Data are expressed as
percentage of control and are means 6 SE. * is p,0.05 and **p,0.01
versus control.
doi:10.1371/journal.pone.0016722.g004
Hydroquinone: Inflammation and Angiogenesis in AMD
PLoS ONE | www.plosone.org 5 February 2011 | Volume 6 | Issue 2 | e16722human AMD prompted us to examine the expression of this major
pro-inflammatory cytokine in patients diagnosed with the disease.
Here, we report for the first time that MCP-1 expression is
markedly decreased in RPE from smoker patients with AMD
thereby pointing to a critical role for MCP-1 in the pathogenesis of
the disease. We acknowledge that due to the nature of our study, it
cannot be determined whether the altered expression of MCP-1 in
human RPE lysates is a cause or consequence of the disease.
However, our current findings suggest that declining MCP-1
production by aging RPE cells may impair recruitment of
macrophages essential for scavenging debris which may lead to
drusen formation and accumulation in AMD patients. Because
Figure 5. Increased VEGF-to-PEDF ratio in human RPE cells following sustained oxidative injury with HQ. Confluent serum-starved
ARPE-19 cells were treated with 10 mM HQ every 24 hours for 5 consecutive days in phenol red-free 0.1% FBS medium. Total RNA was extracted to
assess (A) VEGF and (D) PEDF mRNA expression by real-time PCR. GAPDH was used as internal control. Supernatants were collected to assess (B)
VEGF and (D) PEDF protein concentration by ELISA. (E) VEGF-to-PEDF protein ratio. Data are mean6 SE and represent the average results of 3
independent experiments run in duplicate. * is p,0.05 versus control.
doi:10.1371/journal.pone.0016722.g005
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linked to the pathogenesis of AMD [66], it can be speculated that
declining RPE-derived MCP-1 production resulting from cumu-
lative exposure to oxidative damage may be an important factor
that could accelerate and promote the progression of early AMD
to CNV in smokers. This theory is put forth bearing in mind the
complexity of underlying cellular and molecular mechanisms
involved in the inflammatory response and with the acknowledg-
ment that numerous AMD genotypes may exist. Therefore, we
fully recognize that only some aspects of the proposed hypothesis
may be involved in any given AMD genotype.
Based on the above hypothesis, we next evaluated the possibility
that HQ-induced oxidative stress might regulate MCP-1 expres-
sion in the RPE. We showed that prolonged exposure to HQ-
induced oxidative injury for 5 days and 3 weeks downregulated
MCP-1 production by ARPE-19 cells and RPE/choroids from
C57BL/6 mice. An earlier study by Joly et al is in line with our
observations showing a decline in MCP-1 gene expression in
retinas of mice exposed to light-induced oxidative damage for
several days [67]. Our findings suggest that diminished infiltration
of scavenging macrophages which might result from decreased
MCP-1 production in response to HQ-induced oxidative injury to
Figure 6. Increased VEGF-to-PEDF ratio in human RPE cells following repetitive oxidative injury with HQ. Confluent serum-starved
ARPE-19 cells were treated with 50 mM HQ every 4 days for 24 hours for 3 consecutive weeks in phenol red-free 0.1% FBS medium. Total RNA was
extracted to assess (A) VEGF and (D) PEDF mRNA expression by real-time PCR. GAPDH was used as internal control. Supernatants were collected to
assess (B) VEGF and (D) PEDF protein concentration by ELISA. (E) VEGF-to-PEDF protein ratio. Data are mean6 SE and represent the average results of
3 independent experiments run in duplicate. * is p,0.05 and *** is p,0.0001 versus control.
doi:10.1371/journal.pone.0016722.g006
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HQ-induced oxidative injury. Total RNA was extracted from microdissected RPE/choroid complexes after 5 days and 3 weeks of exposure to HQ in
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overwhelming drusen accumulation which has been shown to be a
risk factor for progression to CNV. Altogether, our findings
highlight a particular significance for MCP-1 in the pathogenesis
of AMD. Our observations suggest that sustained exposure to
oxidative stress might impair RPE-derived MCP-1-mediated
scavenging macrophages recruitment and phagocytosis which
might lead to incomplete clearance of proinflammatory debris,
infiltration of proangiogenic macrophages and ultimately to
progressive drusen accumulation and CNV in smoker patients
with AMD.
Inappropriate expression of VEGF and PEDF promoting
functional overactivity of proangiogenic signaling has been
associated to CNV [40]. We report here that VEGF expression
is increased and PEDF expression is decreased in RPE from
smoker patients with AMD resulting in an increased VEGF-to-
PEDF ratio. A disruption in the critical balance of these opposing
stimuli that may be permissive for the development of wet AMD.
Our findings are consistent with clinical observations describing
dysregulated expression of VEGF and PEDF [46,47,48,53,54,56]
in eyes with AMD. Oxidant-mediated RPE damage might
promote abnormal angiogenesis [40]. Therefore, we next
investigated whether HQ-induced oxidative stress might also
regulate VEGF and PEDF expression in RPE cells. In vitro,
although oxidative injury declined the production of PEDF
without significantly changing VEGF expression in ARPE-19 cells
regardless of dose and duration of exposure to HQ, we observed
an increased VEGF-to-PEDF ratio which may favor angiogenesis.
These results suggest that cigarette smoke-related HQ-induced
oxidative stress might impair the delicate balance between VEGF
and PEDF that controls angiogenic homeostasis in the retina.
Other previous reports showed that cigarette smoke extract
induces VEGF expression in ARPE-19 cells [23] and that
H2O2-induced oxidative stress increased the production of VEGF
in human RPE cells [40]. The discrepancy between our in vitro
findings and those earlier observations with regards to VEGF
might reflect differences in cellular responses in the setting of
different types of oxidant-mediated injury. The endogenous
angiogenic inhibitors are believed to be essential for maintaining
the homeostasis of angiogenesis in the retina. Given the evidence
that PEDF is an important negative regulator of angiogenesis,
lower levels of PEDF is strongly suggestive of a decreased anti-
angiogenic activity that may lead to the initiation of angiogenesis
in response to HQ-induced oxidative stress. However, we do not
rule out the possibility that a decreased level of inhibitory factor
PEDF by itself may not be sufficient for inducing the angiogenic
switch leading to CNV. Reciprocal increase in stimulatory VEGF
might also be needed. In fact, a longer more sustained exposure to
HQ might be necessary to induce VEGF expression in ARPE-19
cells. Furthermore, angiogenesis is a highly complex and tightly
orchestrated multistep process involving extensive interplay
between multiple angiogenic factors. It is therefore possible that
several other molecules besides VEGF and PEDF regulated by
HQ might permit the development of abnormal angiogenesis. In
vivo, we observed elevated expression of VEGF and PEDF protein
in RPE/choroids from HQ-treated mice which translated into an
enhanced VEGF-to-PEDF ratio. As stated earlier, important
species-specific differences may also account for the discrepancy
between human cells and mice results. In addition, one has to keep
in mind that inherent in vitro and in vivo differences might explain
this disparity. PEDF has multiple dose-dependent biological
functions. Interestingly, it has been reported that low doses of
PEDF are inhibitory but high doses can increase the development
of CNV induced by laser in mice [68]. In addition, a study showed
that RPE-derived VEGF upregulates PEDF expression via VEGF
receptor-1 in an autocrine manner [69], therefore highlighting
regulatory interactions between these two counterbalancing
systems of angiogenic stimulators and inhibitors. In any case,
our in vivo findings confirm that HQ-induced oxidative damage is
unequivocally associated with an imbalance between VEGF and
PEDF in the RPE.
In summary, our data provide strong support for a key role
played by injured RPE cells in the progression of dry AMD to
CNV. We demonstrated that RPE dysfunction might lead to
dysregulation of macrophage clearance function and angiogenic
homeostasis as a result of oxidative damage which may trigger
progression towards CNV in smoker patients with dry AMD.
Materials and Methods
Animal Ethics Statement
C57BL/6 mice were obtained from Jackson Laboratories (Bar
Harbor, MN) and maintained at the McKnight Vision Research
Center at University of Miami Miller School of Medicine in
compliance with institutional regulations. University of Miami was
granted full accreditation by the Association for Assessment and
Accreditation of Laboratory Animal Care, International. This
study was conducted according to the Association for Research in
Vision and Ophthalmology statement for the Use of Animals in
Ophthalmic and Vision Research and was approved under the
University of Miami Care and Use Committee protocol number
10-050. The experiments were carried out in accordance with the
Animal Welfare Act provisions and all other animal welfare
guidelines for the Care and Use of Laboratory Animals.
Human Ethics Statement
Human RPE lysates were prepared from cadaver eyes obtained
from the Florida Lions Eye Bank determined unsuitable for
transplantation (Miami, FL) (n=4 patients diagnosed with AMD
and n=4 control non-smoker donors with no known history of eye
disease). Methods for securing these eyes were humane, included
proper written consent and approval and complied with the tenets
of the Declaration of Helsinki. Written consent for the use of the
eyes was obtained by the eye bank either through premortem
instructions or from postmortem next of kin. The research was
conducted with local University of Miami Institutional Review
Boards committee approval (IRB # 19920231). Table 1 provides
available information about the eye donors.
Cells and treatments
ARPE-19 cells, a human retinal pigment epithelial cell line [70]
obtained from American Type Culture Collection (Manassas, VA)
drinking water (0.8%). VEGF and PEDF mRNA expression was measured by real-time PCR. GAPDH was used as internal control (n=5 eyes per group).
(C) VEGF and PEDF protein expression in response to HQ-induced oxidative injury. (D) VEGF-to-PEDF protein ratio. Total protein was extracted from
microdissected RPE/choroid complexes after 5 days and 3 weeks of exposure to HQ in drinking water (0.8%). Equivalent amounts of protein from 5
eyes per group were pooled for each lane. VEGF and PEDF protein expression was evaluated by Western blot and normalized to GAPDH. Top:
representative Western blots of the indicated proteins. The numbers to the left are molecular weights in kilodaltons (KDa). Bottom: average
densitometry results. Data are expressed as percentage of control and are means 6 SE. * is p,0.05 and **p,0.01 versus control.
doi:10.1371/journal.pone.0016722.g007
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Medium/Ham’s F-12 (DMEM/F12) (1:1 vol/vol) medium
supplemented with 10% fetal bovine serum (FBS), 1 mM L-
glutamine, 100 mg/ml penicillin/streptomycin, and 0.348%
Na2CO3 in a 5% CO2 humidified air incubator at 37uC.
ARPE-19 cells are spontaneously immortalized human RPE cells
that form polarized epithelial monolayers, are accepted as a model
of RPE behavior and have been used in many studies. It has been
demonstrated that ARPE-19 cells have structural and functional
properties characteristic of RPE cells in vivo therefore suggesting
that this cell line is valuable for in vitro studies of RPE physiology
[70]. Cells were used between passage 5 and 8. For experiments,
cells were split and plated at sub-confluent density in six-well and
twenty four-well plates and grown to confluence. At the time of
confluence, the medium was replaced for 48 hours with phenol
red-free DMEM/F12 supplemented with 10% FBS medium.
Subsequently, cells were treated following 2 protocols: Protocol 1
(sustained injury): HQ 10 mM every 24 hours for 5 days in phenol
red-free DMEM/F12 supplemented with 1% FBS medium;
Protocol 2 (repetitive injury): HQ 50 mM for 24 hours every 4
days for 3 weeks in phenol red-free DMEM/F12 supplemented
with 0.1% FBS medium. The number of surviving cells was
measured by cell count at the end of the treatment (Z1 Coulter
Particle Counter, Beckman Coulter, Hialeah, FL) After treatment,
supernatants were collected and cells were washed with phosphate
buffered saline (PBS) and harvested in TRI Reagent (Sigma-
Aldrich, St Louis, MO) for RNA extraction. All experiments
(triplicate wells for each condition) were performed in triplicate
wells at least in triplicate.
Animals
Four-month-old male C57BL/6 mice were divided into
3groups: Group 1: control mice receiving regular drinking tap
water (n=5); Group 32: mice receiving HQ orally in drinking
water (0.8% HQ) for 5 days (n=5); Group 3: mice receiving HQ
orally in drinking water (0.8% HQ) for 3 weeks (n=5). Mice were
housed in plastic cages with free access to food and water, and
were kept on a 12-hour light–dark cycle. At the end of the
experimental period, mice were euthanized with CO2 and eyes
were immediately removed and microdissected for recovery of
RPE/choroid sheets as previously described [71]. Total RNA and
protein were extracted and stored at 280uC.
Western blot
Western blot analysis was performed as previously described
[29]. As information on smoking status as unavailable for one
AMD donor, only 3 smoker patients with AMD and 3 non smoker
controls were included in each group. Total protein was extracted
in protein lysis buffer M-PER (Pierce, Rockford, IL) from human
RPE and RPE/choroids isolated from mice and quantified by a
Detergent Compatible protein assay (Bio-Rad, Hercules, CA). The
primary antibodies used were as follows: anti-MCP-1 (dilution
1:500, Cell Signaling, Danvers, MA), anti-VEGF (dilution 1:500,
LifeSpan, Seattle, WA) and anti-PEDF (dilution 1:500, R&D
Systems, Minneapolis, MN). Equal loading of gels was confirmed
both by Ponceau S (Sigma-Aldrich, St Louis, MO) staining of
membranes and GAPDH detection (Cell Signaling, Danvers,
MA). The secondary antibodies used were horseradish-peroxidase-
linked donkey anti-rabbit, anti-mouse or anti-goat (1:1,000, Santa
Cruz, Santa Cruz, CA).




Age Gender Smoker Age Gender Smoker
16 4 M N o
28 5 F N o
36 9 M N o
47 4 M N o
57 0 M Y e s
66 8 M Y e s
78 1 M ?
87 5 M Y e s
F, female; M, male.
? Information on smoking status was unavailable.
doi:10.1371/journal.pone.0016722.t001
Table 2. Real-time PCR Primers.
Target Gene Forward Primer Reverse Primer Size (bp)
Human
GAPDH tgc acc acc aac tgc tta gc ggc atg gac tgt ggt cat gag 87
MCP-1 gtc tct gcc gcc ctt ctg t ttg cat ctg gct gag cga g 76
VEGF agg agg agg gca gaa tca tca ctc gat tgg atg gca gta gct 76
PEDF tcc aat gca gag gag tag ca tgt gca ggc tta gag gga ct 93
RelA/p65 ggt ccg ctg aaa gga ctc tt gaa ttc cag tac ctg cca ga 110
IkB-a aaa gcc agg tct ccc ttc ac cag cag ctc acc gag gac 107
Mouse
GAPDH cat ggc cct ccg tgt tcc ta gcg gca cgt cag atc ca 55
MCP-1 agg tgt ccc aaa gaa get gta atg tct gga ccc att cct tct 85
VEGF gga gat cct tcg agg agc act t ggc gat tta gca gca gat ata aga a 130
PEDF tcg aaa gca gcc ctg tgt t aat cac ccg act tca gca aga N/A
N/A=not available.
doi:10.1371/journal.pone.0016722.t002
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RNA extraction and real-time PCR were performed as
previously described [29]. RNA was extracted in TRI reagent
(Sigma-Aldrich, St Louis, MO) from ARPE-19 cells and RPE/
choroids isolated from mice. Primer sequences and size of the
product for each targeted gene are described in Table 2. Human
and mouse GAPDH, MCP-1, VEGF and human PEDF primer
sequences are available in the public RTPrimerDB database
(http://medgen.UGent.be/rtprimerdb/) [72]. Mouse PEDF primer
sequences were previously published [73]. Human Ik-Ba and
RelA/p65 primer sequences are available in the qPrimerDepot
database (http://primerdepot.nci.nih.gov/).
ELISA
Cell supernatants were collected and protein concentration was
determined by a Detergent Compatible protein assay. Concen-
trations of MCP-1, VEGF (R&D Systems, Minneapolis, MN) and
PEDF (Millipore Corporation, Bedford, MA) were determined
using ELISA kits following manufacturer’s instructions. MCP-1,
VEGF and PEDF levels were expressed relative to total protein
(ng/mg of total protein) and subsequently expressed as % of
control. All assays were done in duplicate.
Statistics
Statistical analysis was performed with GraphPad Prism 4.0
(San Diego, CA). Data are expressed as percentage of the control
and presented as means 6 SEM of three to six independent
experiments performed in triplicate. Statistical analysis of data was
performed by using a one-way ANOVA followed by either a
Dunnett or a Bonferroni multiple comparison post-hoc test, or the
Student’s t test. The level of significance accepted was p,0.05.
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